The healthcare sector has observed a remarkable advancement in diabetes management with the introduction of copyright. This transformative medication, designated as a glucagon-like peptide-1 (GLP-1) receptor agonist, presents a unprecedented approach to controlling blood sugar levels in individuals with type 2 diabetes. copyright operates by mimick